Investors
Stock
Information
EURONEXT PARIS / B COMPARTMENT
FR0004065605 / MEDCL
25,151,653
KEPLER CHEUVREUX
BRYAN GARNIER & CO
KEPLER CHEUVREUX
ODDO-BHF
Investors
Events &
Presentations
PREVIOUS EVENTS
September 08, 2022
General Meeting (French)
Replay
September 05, 2022
Videoconference • General meeting preparation (French)
Replay
April 23, 2020
Video Conference • Adapt and overcome to the Covid-19 crisis
Replay
See all
Session en français
Rendez-vous le lundi 14 novembre à 18h00 (CET) pour une vidéoconférence dédiée aux récentes avancées des produits de notre portfeuille clinique
English session
On Monday 14, November at 6.00 pm (CET) participate in our videoconference dedicated to the latest news regarding our clinical and regulatory products
INVESTORS
Regulated informations
Jan. 2023 Half-year Liquidity contract statement
July 2022 Half-year Liquidity contract statement
Jan. 2022 Half-year liquidity contract statement
See allJuly 2021 Half-year liquidity contract statement
Jan. 2021 Half-year liquidity contract statement
July 2020 Half-year liquidity contract statement
Jan. 2020 Half-year liquidity contract statement
Jan. 2020 Half-Year liquidity contract report (French)
Shares & Voting rights
See allAnnual reports
See allInvestors
General
Meeting
September 2022
See all
See all
See all
See all
See all
Investors
Contacts
MedinCell
Head of Communication / IR
David Heuzé
david.heuze@medincell.com
+33 (0)6 83 25 21 86
MedinCell
Senior Communications Officer
Nicolas Gourgues
nicolas.gourgues@medincell.com
Investor Relations
NewCap
Louis-Victor Delouvrier & Mathilde Bohin
medincell@newcap.eu
+33 (0)1 44 71 94 94
Media
NewCap
Nicolas Merigeau
medincell@newcap.eu
+33 (0)1 44 71 94 94